国: オーストラリア
言語: 英語
ソース: Department of Health (Therapeutic Goods Administration)
Factor IX, Quantity: 3500 IU
CSL Behring Australia Pty Ltd
Solution
Excipient Ingredients:
Intravenous
3500 IU
Not scheduled. Not considered by committee
IDELVION is indicated in all patients with haemophilia B for:,? Routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? Control and prevention of bleeding episodes,? Control and prevention of bleeding in the perioperative setting.
Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store between 2 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2020-11-19